This invention provides a novel class of nicotine analogs which as therapeutic agents exhibit tranquilizing effects in mammals.
Illustrative of an invention nicotine analog is 1-(3-dimethylaminopropyl)-2-(3-pyridyl)pyrrolidine:
The nicotine analogs can exist in the form of acid addition salts.
A method of preparing such nicotine analogs is also disclosed.